Pediatric poisonings in Israel: National Poison Center data

Yedidia Bentur1, Natalia Desiatnic Obchinikov, Alfred Cahana

  • 1Israel Poison Information Center, Rambam Health Care Campus, affiliated with Rappaport Faculty of Medicine, Technion-lsrael Institute of Technology, Haifa, Israel. d_bentur@rambam.health.gov.il

Insights

Pediatric poisonings are a major health concern, with most exposures occurring in young children and being unintentional. Adolescents face more severe poisonings, often intentional, highlighting the need for enhanced prevention and management strategies.

Area of Science:

  • Pediatric Toxicology
  • Epidemiology
  • Public Health

Background:

  • Poisonings represent a significant cause of pediatric morbidity and mortality.
  • The Israel Poison Information Center offers 24-hour clinical consultations for poisonings and drug information.

Purpose of the Study:

  • To evaluate the epidemiologic characteristics of pediatric poison exposures in Israel.
  • To analyze trends in pediatric poisoning cases reported to a national poison center.

Main Methods:

  • Descriptive analysis of a national Poison Center database.
  • Review of computerized queries for patients under 18 years old in 2007.

Main Results:

  • 15,005 pediatric poison exposures were recorded, with 80.3% in children under 6.
  • Most exposures were unintentional, occurred at home, and involved common household substances.
  • Adolescent poisonings were more frequently intentional, severe, and required emergency care.

Conclusions:

  • Pediatric poisonings are a significant public health issue, particularly affecting young children and adolescents.
  • Adolescent poisonings exhibit higher severity, likely due to intentional self-harm.
  • Enhanced national efforts in poison prevention, management, and registry creation are crucial.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...